Dilliard, Sean A. http://orcid.org/0000-0002-5884-8392
Siegwart, Daniel J. http://orcid.org/0000-0003-3823-1931
Article History
First Online: 21 February 2022
Competing interests
: D.J.S. is a co-founder and consultant of ReCode Therapeutics, which has licensed intellectual property from UT Southwestern. S.A.D. and D.J.S. are listed as co-inventors on patent applications related to nanoparticle delivery that are filed and owned by the Reagents of the University of Texas System.
Free to read: This content has been made available to all.